Raymond James Financial Inc. Invests $1.10 Million in Phibro Animal Health Co. (NASDAQ:PAHC)

Raymond James Financial Inc. bought a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 52,503 shares of the company's stock, valued at approximately $1,103,000. Raymond James Financial Inc. owned 0.13% of Phibro Animal Health at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in PAHC. Quantbot Technologies LP increased its position in shares of Phibro Animal Health by 65.1% during the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after purchasing an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Phibro Animal Health during the fourth quarter worth $113,000. New York State Teachers Retirement System raised its position in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after buying an additional 775 shares during the last quarter. Amundi lifted its stake in shares of Phibro Animal Health by 185.5% in the fourth quarter. Amundi now owns 9,855 shares of the company's stock worth $212,000 after buying an additional 6,403 shares in the last quarter. Finally, Envestnet Asset Management Inc. acquired a new position in Phibro Animal Health during the fourth quarter worth about $219,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Trading Up 14.7 %

Shares of NASDAQ:PAHC traded up $2.86 during midday trading on Thursday, reaching $22.25. 670,125 shares of the company's stock were exchanged, compared to its average volume of 192,827. The firm's 50 day simple moving average is $20.07 and its two-hundred day simple moving average is $21.88. Phibro Animal Health Co. has a fifty-two week low of $16.06 and a fifty-two week high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a market cap of $901.19 million, a price-to-earnings ratio of 46.35, a P/E/G ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The business had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. As a group, sell-side analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.16%. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.

Analyst Ratings Changes

PAHC has been the topic of a number of research reports. Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday. Finally, StockNews.com cut shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, Phibro Animal Health has an average rating of "Hold" and a consensus price target of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.